zoledronic acid has been researched along with Diabetic Neuropathies in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Bhansali, A; Das, L; Dutta, P; Jude, EB; Prakash, M; Rastogi, A | 1 |
| Lahtela, J; Laine, HJ; Mäenpää, H; Mattila, P; Pakarinen, TK | 1 |
| Collet, P; Marotte, H; Nizeica, V | 1 |
2 trial(s) available for zoledronic acid and Diabetic Neuropathies
| Article | Year |
|---|---|
Long-term foot outcomes following differential abatement of inflammation and osteoclastogenesis for active Charcot neuroarthropathy in diabetes mellitus.
Topics: Anti-Inflammatory Agents; Arthropathy, Neurogenic; Bone Density; Bone Density Conservation Agents; Diabetes Mellitus, Type 2; Diabetic Foot; Diabetic Neuropathies; Female; Humans; Inflammation; Male; Methylprednisolone; Middle Aged; Osteogenesis; Treatment Outcome; Zoledronic Acid | 2021 |
The effect of zoledronic acid on the clinical resolution of Charcot neuroarthropathy: a pilot randomized controlled trial.
Topics: Adult; Arthropathy, Neurogenic; Diabetic Neuropathies; Diphosphonates; Double-Blind Method; Female; Foot Diseases; Humans; Imidazoles; Male; Middle Aged; Pilot Projects; Zoledronic Acid | 2011 |
1 other study(ies) available for zoledronic acid and Diabetic Neuropathies
| Article | Year |
|---|---|
Bortezomib induced a phrenic palsy in a multiple myeloma patient.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Density Conservation Agents; Boronic Acids; Bortezomib; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Diagnosis, Differential; Diphosphonates; gamma-Aminobutyric Acid; Humans; Imidazoles; Male; Melphalan; Multiple Myeloma; Nerve Compression Syndromes; Neuralgia; Phrenic Nerve; Prednisone; Pregabalin; Protease Inhibitors; Pyrazines; Respiratory Paralysis; Zoledronic Acid | 2013 |